arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

EBR Systems, Inc.

EBRCZ
Price unavailable
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
14 Visible periods
25 Metrics
Peer-ranked Benchmarks
Price Chart
23
Health
Poor
Bearish
auto_awesome

Analytical Summary

EBR Systems, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Debt to Equity. The fundamentals warrant careful consideration of downside risks.

Market Cap
Dividend Yield
Revenue Growth
Op. Margin
ROIC -24.9%
FCF / Share $-0.52
Trailing P/E
Price / Book
FCF Yield
Debt / Equity 4.38
info Valuation on last close.

14-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$2.36M
↑ +152.6%
Net Income Profit after all expenses
$-17.07M
↓ -61.8%
FCF / Share Free cash flow per share
$-0.52
↓ -1329.2%
Long-Term Debt Long-term obligations
$41.80M
— 0.0%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
3
Financial Health
24
Cash Quality
71

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 4 years · 14 quarters